New Developments in Anti-Platelet Therapies Potential Use of CD39/Vascular ATP Diphosphohydrolase in Thrombotic Disorders
Journal:
Current Drug Targets
Volume:
1
Page:
285-296
Author(s):
Imrana Qawi and Simon C. Robson
Use of Recombinant Human Erythropoietin as an Antianemic and Performance Enhancing Drug
Journal:
Current Pharmaceutical Biotechnology
Volume:
1
Page:
11-31
Author(s):
W. Jelkmann
Withdrawal Notice: Therapeutic Effect of Prdx1 on NAFLD Mice May be Related to the Activation of Nrf-2/HO-1 Pathway
Journal:
Current Pharmaceutical Design
Volume:
26
Page:
1-1
Author(s):
Ru-Xue Bai, Ying-Ying Xu, Yan-Ming Chen, Geng Qin, Hui-Fen Wang and Shi-Yu Du*
Withdrawn: Mesenchymal Stem Cell-derived Exosomes for Treatment of Ischemic Stroke
Journal:
Current Stem Cell Research & Therapy
Volume:
16
Page:
1-1
Author(s):
Rucheng Liu , Yi Zhang, Yundi Zhang*, Maryam Farzaneh* and Seyed Esmaeil Khoshnam